期刊
SCIENCE
卷 301, 期 5639, 页码 1535-1537出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1086845
关键词
-
Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/ AIDS) has dramatically increased the incidence of tuberculosis (TB) in sub-Saharan Africa, where up to 60% of TB patients are coinfected with HIV and each year 200,000 TB deaths are attributable to HIV coinfection. Now HIV threatens control of TB in Asia, Eastern Europe, and Latin America. Antiretroviral ( ARV) drugs can prevent TB by preserving immunity, but cohort analysis shows that early therapy, plus high levels of coverage and compliance, will be needed to avert a significant fraction of TB cases. However, ARV drugs could enhance the treatment of TB, and TB programs provide an important entry point for the treatment of HIV/ AIDS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据